Bottom Line:
💡 BUY OPPORTUNITY: M shows positive signals but monitor for confirmation. Market pricing in 4.0% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)50% (Hyper Growth)
EST. PRICE IN 2031
$20.42
Based on 0.6% avg growth
INTRINSIC VALUE TODAY
$12.68
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.3x Exit PE.
Valuation Analysis: M is currently trading at $17.58, which is considered slightly low relative to its 30-day fair value range of $17.27 to $20.22. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.2) compared to its historical average (9.3). Remarkably, the market is currently pricing in an annual earnings decline of 4.0% over the next few years. This pessimistic expectation contrasts with the company's recent 52.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, M is in a strong uptrend. Immediate support is located at $16.69, while resistance sits at $18.95.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$17.27 -
$20.22
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
BULLISH: Price oversold vs 30-day range
NEUTRAL: Mixed technical signals (45/100)
BULLISH: High volume confirmation
NEUTRAL: Near Wall St target ($19.30)
Fair Price Analysis
30-Day Fair Range
$17.27 -
$20.22
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level$16.69
Resistance Level$18.95
Current TrendStrong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)8.22
Wall Street Target
$19.30
(+9.8%)
Revenue Growth (YoY)-1.1%
Earnings Growth (YoY)52.0%
Profit Margin2.8%
Valuation Discount vs History
-4.0% cheaper
PE vs Historical
8.2 vs 9.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):-4.0%
(market-implied from PE analysis)
1-Year Target
$16.88
(-4%)
2-Year Target
$16.20
(-8%)
3-Year Target
$15.55
(-12%)
3-Yr Target (if PE normalizes)
(PE: 8→9)
$17.60
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: -2.9%)
$43.78
(+149%)
Base:
(SPY PE: 8.2, Growth: -2.9%)
$16.09
(-8%)
Bear:
(PE: 7.0, Growth: -2.9%)
$13.68
(-22%)
📈Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (11x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 10.51 | Current EPS (TTM): $1.70
Bull Case
$24.74
(+37%)
Analyst growth 25.9%, PE expands to 11.6
Base Case
$22.49
(+25%)
Market implied 25.9%, PE stable at 10.5
Bear Case
$12.15
(-33%)
Severe decline -20.0%, PE contracts to 8.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.2 to 9.3
Stabilization Target:
$19.90
(+13.2%)
PE Expansion Potential:
+13.2%
Share & Embed Analysis
Found this analysis useful? Share it with your community or embed the live chart on your blog.
Founded in 1858 and based in New York City, Macy's operates about 450 stores under the Macy's name, nearly 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and more than 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constitute about 62% of Macy's sales.